Emerging as a promising breakthrough in the battle against obesity, this medication is generating considerable interest . This treatment combines properties of two established GLP-1 receptor agonists, semaglutide , plus an unique glucose-dependent peptide component. Initial patient results have indicated impressive weight reduction in patients w… Read More